HIV and antiretroviral therapy-related fat alterations

Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy

(2020) Jordan E Lake et al.   CLINICAL INFECTIOUS DISEASES

Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

(2020) Kassem Bourgi et al.   Journal of the International AIDS Society

Adipogenesis and metabolic health

(2019) Alexandra L. Ghaben et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Reduction of HIV-1 Reservoir Size and Diversity After 1 Year of cART Among Brazilian Individuals Starting Treatment During Early Stages of Acute Infection

(2019) Thaysse Ferreira Leite et al.   Frontiers in Microbiology

Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients

(2019) J.-P. Bastard et al.   DIABETES & METABOLISM

Impact of HIV/SIV infection and viral proteins on adipose tissue fibrosis and adipogenesis

(2019) Jennifer Gorwood et al.   AIDS

Greater Weight Gain in Treatment Naïve Persons Starting Dolutegravir-Based Antiretroviral Therapy

(2019) Kassem Bourgi et al.   CLINICAL INFECTIOUS DISEASES

Testosterone replacement therapy and cardiovascular risk

(2019) Thiago Gagliano-Jucá et al.   Nature Reviews Cardiology

Metabolic complications affecting adipose tissue, lipid and glucose metabolism associated with HIV antiretroviral treatment

(2019) Claire Lagathu et al.   Expert Opinion On Drug Safety

Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study

(2019) Christine Katlama et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The endocrine function of adipose tissues in health and cardiometabolic disease

(2019) Ludger Scheja et al.   Nature Reviews Endocrinology

Midlife adiposity predicts cognitive decline in the prospective Multicenter AIDS Cohort Study

(2019) Leah H. Rubin et al.   NEUROLOGY

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

(2019) Willem D.F. Venter et al.   NEW ENGLAND JOURNAL OF MEDICINE

HIV , antiretroviral therapy and non‐communicable diseases in sub‐Saharan Africa: empirical evidence from 44 countries over the period 2000 to 2016

(2019) Lelani Coetzee et al.   Journal of the International AIDS Society

Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients

(2019) Sebastiano Rizzardo et al.   AIDS

No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV

(2019) James Edward Burns et al.   AIDS

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

(2019) Paul E Sax et al.   CLINICAL INFECTIOUS DISEASES

Brief Report

(2019) Suman Srinivasa et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial

(2019) Takara L Stanley et al.   Lancet HIV

Abdominal obesity, sarcopenia, and osteoporosis are associated with frailty in men living with and without HIV

(2018) Kellie L. Hawkins et al.   AIDS

Adipocytes impair efficacy of antiretroviral therapy

(2018) Jacob Couturier et al.   ANTIVIRAL RESEARCH

GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials

(2018) Xiaoming Jia et al.   CARDIOVASCULAR DRUGS AND THERAPY

Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors

(2018) David R Bakal et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

“We're stuck with what we've got”: The impact of lipodystrophy on body image

(2018) Claire Adams et al.   JOURNAL OF CLINICAL NURSING

Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone

(2018) Netanya S Utay et al.   JOURNAL OF INFECTIOUS DISEASES

Sleeve Gastrectomy in Morbidly Obese HIV Patients: Focus on Anti-retroviral Treatment Absorption After Surgery

(2018) Chloé Amouyal et al.   OBESITY SURGERY

The Effect of Bariatric Surgery on Patients with HIV Infection: a Literature Review

(2018) Khalid Akbari et al.   OBESITY SURGERY

Microbial translocation

(2018) Alexandra M. Ortiz et al.   Current Opinion in HIV and AIDS

Induction and Maintenance of CX3CR1-Intermediate Peripheral Memory CD8 + T Cells by Persistent Viruses and Vaccines

(2018) Claire Louse Gordon et al.   Cell Reports

Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral Therapy

(2018) Vanessa El Kamari et al.   CLINICAL INFECTIOUS DISEASES

High CD8 T Cell Receptor Clonality and Altered CDR3 Properties are Associated with Elevated Isolevuglandins in Adipose Tissue During Diet-Induced Obesity

(2018) Wyatt J. McDonnell et al.   DIABETES

Prior exposure to thymidine analogues and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors

(2018) Marco Gelpi et al.   AIDS

Diagnostic accuracy of noninvasive markers of steatosis, NASH and liver fibrosis in HIV-monoinfected individuals at-risk of non-alcoholic fatty liver disease (NAFLD)

(2018) Maud Lemoine et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Progressive increases in fat mass occur in adults living with HIV on antiretroviral therapy, but patterns differ by sex and anatomic depot

(2018) Paula Debroy et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Metabolic risk factors in young adults infected with HIV since childhood compared with the general population

(2018) Elise Arrive et al.   PLoS One

Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy

(2018) James B. Whitney et al.   Nature Communications

Age-Induced Changes in White, Brite, and Brown Adipose Depots: A Mini-Review

(2017) Markus Schosserer et al.   GERONTOLOGY

GH administration decreases subcutaneous abdominal adipocyte size in men with abdominal obesity

(2017) Miriam A. Bredella et al.   GROWTH HORMONE & IGF RESEARCH

Adipose Tissue is Enriched for Activated and Late-differentiated CD8+ T cells, and Shows Distinct CD8+ Receptor Usage, Compared to Blood in HIV-infected Persons

(2017) John R. Koethe et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Microbiome of HIV-infected people

(2017) Grégory Dubourg et al.   MICROBIAL PATHOGENESIS

Adipose-derived circulating miRNAs regulate gene expression in other tissues

(2017) Thomas Thomou et al.   NATURE

Heart fat in HIV

(2017) Jonathan Buggey et al.   Current Opinion in HIV and AIDS

The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection

(2017) Jordan E. Lake   Current HIV/AIDS Reports

HIV Infection Is Associated with Increased Fatty Infiltration of the Thigh Muscle with Aging Independent of Fat Distribution

(2017) Javzandulam Natsag et al.   PLoS One

Lipodystrophy syndrome in HIV-infected children on HAART

(2017) Steve Innes et al.   SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE

Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers

(2017) Jan Vesterbacka et al.   Scientific Reports

The gut microbiome and HIV-1 pathogenesis

(2016) Stephanie M. Dillon et al.   AIDS

Long-term body composition changes in antiretroviral-treated HIV-infected individuals

(2016) Philip M. Grant et al.   AIDS

Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada

(2016) John R. Koethe et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway

(2016) Rana Al-Sadi et al.   AMERICAN JOURNAL OF PATHOLOGY

Impact of elvitegravir on human adipocytes: Alterations in differentiation, gene expression and release of adipokines and cytokines

(2016) Ricardo Moure et al.   ANTIVIRAL RESEARCH

LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation

(2016) Pauline Afonso et al.   ATHEROSCLEROSIS

Beyond viral suppression of HIV – the new quality of life frontier

(2016) Jeffrey V. Lazarus et al.   BMC Medicine

Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome

(2016) Cynthia L. Monaco et al.   Cell Host & Microbe

Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s

(2016) Grace A. McComsey et al.   CLINICAL INFECTIOUS DISEASES

Quality of life outcomes associated with treatment of human immunodeficiency virus (HIV) facial lipoatrophy

(2016) Christina N. Kraus et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events

(2016) Rohan Khera et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Dysfunctional Subcutaneous Fat With Reduced Dicer and Brown Adipose Tissue Gene Expression in HIV-Infected Patients

(2016) Martin Torriani et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline

(2016) Rebecca J. Brown et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

ATP-Induced Inflammation Drives Tissue-Resident Th17 Cells in Metabolically Unhealthy Obesity

(2016) Julieta B. Pandolfi et al.   JOURNAL OF IMMUNOLOGY

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

(2016)   LANCET

Bariatric surgery for obesity and metabolic disorders: state of the art

(2016) Ninh T. Nguyen et al.   Nature Reviews Gastroenterology & Hepatology

Infectious SIV resides in adipose tissue and induces metabolic defects in chronically infected rhesus macaques

(2016) Jacob Couturier et al.   Retrovirology

Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium

(2016) Annette Pachnio et al.   PLoS Pathogens

Gut Microbiota Linked to Sexual Preference and HIV Infection

(2016) Marc Noguera-Julian et al.   EBioMedicine

Human adipose tissue as a reservoir for memory CD4+ T cells and HIV

(2015) Jacob Couturier et al.   AIDS

Gut microbiota diversity predicts immune status in HIV-1 infection

(2015) Piotr Nowak et al.   AIDS

An evaluation of quality of life and its determinants among people living with HIV/AIDS from Southern Brazil

(2015) Susane Müller Klug Passos et al.   Cadernos de Saude Publica

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Abdominal Obesity Contributes to Neurocognitive Impairment in HIV-Infected Patients With Increased Inflammation and Immune Activation

(2015) Fred R. Sattler et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Abdominal obesity: a marker of ectopic fat accumulation

(2015) Ulf Smith   JOURNAL OF CLINICAL INVESTIGATION

A systematic review of filler agents for aesthetic treatment of HIV facial lipoatrophy (FLA)

(2015) Jared Jagdeo et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

(2015) Xavier Pi-Sunyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adipose Tissue: Sanctuary for HIV/SIV Persistence and Replication

(2015) Suresh Pallikkuth et al.   TRENDS IN MICROBIOLOGY

HIV/AIDS and lipodystrophy: Implications for clinical management in resource-limited settings

(2015) Julia L Finkelstein et al.   Journal of the International AIDS Society

The gut microbiome in cardio-metabolic health

(2015) Tue H Hansen et al.   Genome Medicine

Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection

(2015) Abderaouf Damouche et al.   PLoS Pathogens

Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disorders

(2015) Charlotte M Verolet et al.   AIDS Research and Therapy

Interleukin-1β mediates macrophage-induced impairment of insulin signaling in human primary adipocytes

(2014) Dan Gao et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Zidovudine induces visceral mitochondrial toxicity and intraabdominal fat gain in a rodent model of lipodystrophy

(2014) Ulrich A Walker et al.   ANTIVIRAL THERAPY

Comparison of Body Composition Changes Between Atazanavir/Ritonavir and Lopinavir/Ritonavir Each in Combination with Tenofovir/Emtricitabine in Antiretroviral-Naïve Patients with HIV-1 Infection

(2014) Graeme J. Moyle et al.   CLINICAL DRUG INVESTIGATION

Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study

(2014) J. Schouten et al.   CLINICAL INFECTIOUS DISEASES

Proposed ratios and cutoffs for the assessment of lipodystrophy in HIV-seropositive individuals

(2014) R A Beraldo et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients With Abdominal Fat Accumulation

(2014) Takara L. Stanley et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Altered miRNA processing disrupts brown/white adipocyte determination and associates with lipodystrophy

(2014) Marcelo A. Mori et al.   JOURNAL OF CLINICAL INVESTIGATION

An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia

(2014) S M Dillon et al.   Mucosal Immunology

Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals

(2014) J F Vázquez-Castellanos et al.   Mucosal Immunology

Psychometric assessment of health-related quality of life and symptom experience in HIV patients treated with antiretroviral therapy

(2014) Christophe Lalanne et al.   QUALITY OF LIFE RESEARCH

Visceral Adiposity and the Risk of Metabolic Syndrome Across Body Mass Index

(2014) Ravi V. Shah et al.   JACC-Cardiovascular Imaging

A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects

(2014) Ece A. Mutlu et al.   PLoS Pathogens

Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population

(2014) Alec Miners et al.   Lancet HIV

Anal microbiota profiles in HIV-positive and HIV-negative MSM

(2013) Guoqin Yu et al.   AIDS

Association Between Specific Adipose Tissue CD4+ T-Cell Populations and Insulin Resistance in Obese Individuals

(2013) Elisa Fabbrini et al.   GASTROENTEROLOGY

Surrogate markers of visceral adipose tissue in treated HIV-infected patients: accuracy of waist circumference determination

(2013) J Falutz et al.   HIV MEDICINE

CD8 T-Cell Activation Is Associated With Lipodystrophy and Visceral Fat Accumulation in Antiretroviral Therapy–Treated Virologically Suppressed HIV-Infected Patients

(2013) Giovanni Guaraldi et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Differentially Altered Molecular Signature of Visceral Adipose Tissue in HIV-1–Associated Lipodystrophy

(2013) José M. Gallego-Escuredo et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

The Role of HIV and Monocytes/Macrophages in Adipose Tissue Biology

(2013) Cecilia M. Shikuma et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Effects of GH on Body Composition and Cardiovascular Risk Markers in Young Men With Abdominal Obesity

(2013) Miriam A. Bredella et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Visceral fat resection in humans: Effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers

(2013) Marcelo M. O. Lima et al.   Obesity

New dynamics in global obesity facing low- and middle-income countries

(2013) B. M. Popkin et al.   Obesity Reviews

Role of Mitochondria in HIV Infection and Associated Metabolic Disorders: Focus on Nonalcoholic Fatty Liver Disease and Lipodystrophy Syndrome

(2013) P. Pérez-Matute et al.   Oxidative Medicine and Cellular Longevity

Systematic Review of Antiretroviral-Associated Lipodystrophy: Lipoatrophy, but Not Central Fat Gain, Is an Antiretroviral Adverse Drug Reaction

(2013) Reneé de Waal et al.   PLoS One

HIV-1 Vpr Induces Adipose Dysfunction in Vivo Through Reciprocal Effects on PPAR/GR Co-Regulation

(2013) N. Agarwal et al.   Science Translational Medicine

Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism

(2013) Ivan Vujkovic-Cvijin et al.   Science Translational Medicine

HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus

(2013) Sharof M. Tugizov et al.   VIROLOGY

Metabolic complications and treatment of perinatally HIV-infected children and adolescents

(2013) Linda Barlow-Mosha et al.   Journal of the International AIDS Society

Lipodystrophy Is Common Among Ethiopian Patients on Highly Active Antiretroviral Therapy but Is Not Associated With Quality of Life or Medication Adherence

(2013) Nasir Tajure Wabe et al.   Therapeutic Innovation & Regulatory Science

High Prevalence and Impact on the Quality of Life of Facial Lipoatrophy and Other Abnormalities in Fat Tissue Distribution in HIV-Infected Patients Treated with Antiretroviral Therapy

(2012) Pascale Leclercq et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Pathogenic Simian Immunodeficiency Virus Infection Is Associated with Expansion of the Enteric Virome

(2012) Scott A. Handley et al.   CELL

Role of MicroRNA Processing in Adipose Tissue in Stress Defense and Longevity

(2012) Marcelo A. Mori et al.   Cell Metabolism

Reduction in Visceral Adiposity Is Associated With an Improved Metabolic Profile in HIV-Infected Patients Receiving Tesamorelin

(2012) T. L. Stanley et al.   CLINICAL INFECTIOUS DISEASES

Limb fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20–80 year-old italian population

(2012) Alessandra Coin et al.   CLINICAL NUTRITION

Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial

(2012) Miriam A Bredella et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Lipodystrophy and reversal of facial lipoatrophy in perinatally HIV-infected children and adolescents after discontinuation of stavudine

(2012) N Sawawiboon et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Mitochondrial DNA Haplogroups and Incidence of Lipodystrophy in HIV-Infected Patients on Long-Term Antiretroviral Therapy

(2012) Andrea De Luca et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Adipogenic/Lipid, Inflammatory, and Mitochondrial Parameters in Subcutaneous Adipose Tissue of Untreated HIV-1–Infected Long-Term Nonprogressors

(2012) Francesc Vidal et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Metabolic Profile in Growth Hormone-Deficient (GHD) Adults after Long-Term Recombinant Human Growth Hormone (rhGH) Therapy

(2012) Kim M. J. A. Claessen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A metagenome-wide association study of gut microbiota in type 2 diabetes

(2012) Junjie Qin et al.   NATURE

Microbial translocation in HIV infection: causes, consequences and treatment opportunities

(2012) Netanya G. Sandler et al.   NATURE REVIEWS MICROBIOLOGY

Hypertension and Obesity in Adults Living in a High HIV Prevalence Rural Area in South Africa

(2012) Abraham Malaza et al.   PLoS One

Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction

(2011) Takara L Stanley et al.   AIDS

Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection

(2011) Rebecca Scherzer et al.   AIDS

Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients

(2011) Giovanni Guaraldi et al.   AIDS

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment

(2011) Jacqueline Capeau et al.   AIDS

LMNA Mutations Induce a Non-Inflammatory Fibrosis and a Brown Fat-Like Dystrophy of Enlarged Cervical Adipose Tissue

(2011) Véronique Béréziat et al.   AMERICAN JOURNAL OF PATHOLOGY

HIV-1 Tat protein impairs adipogenesis and induces the expression and secretion of proinflammatory cytokines in human SGBS adipocytes

(2011) Julieta Díaz-Delfín et al.   ANTIVIRAL THERAPY

Effects of ritonavir-boosted darunavir, atazanavir and lopinavir on adipose functions and insulin sensitivity in murine and human adipocytes

(2011) Emilie Capel et al.   ANTIVIRAL THERAPY

Adipose tissue biology and HIV-infection

(2011) Marta Giralt et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s

(2011) G. A. McComsey et al.   CLINICAL INFECTIOUS DISEASES

Long-term Treatment With Raltegravir or Efavirenz Combined With Tenofovir/Emtricitabine for Treatment-Naive Human Immunodeficiency Virus-1–Infected Patients: 156-Week Results From STARTMRK

(2011) Jürgen K. Rockstroh et al.   CLINICAL INFECTIOUS DISEASES

Neutral Actions of Raltegravir on Adipogenesis, Glucose Metabolism and Lipolysis in 3T3-L1 Adipocytes

(2011) Patricia Perez-Matute et al.   CURRENT HIV RESEARCH

Tesamorelin

(2011) Sohita Dhillon   DRUGS

Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD)

(2011) Sang Hoon Han et al.   ENDOCRINE JOURNAL

Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients

(2011) SME Vrouenraets et al.   HIV MEDICINE

Molecular Characterization of Stool Microbiota in HIV-Infected Subjects by Panbacterial and Order-Level 16S Ribosomal DNA (rDNA) Quantification and Correlations With Immune Activation

(2011) Collin L Ellis et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Specific expression of GPR56 by human cytotoxic lymphocytes

(2011) Yen-Ming Peng et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Evidence for Polymicrobic Flora Translocating in Peripheral Blood of HIV-Infected Patients with Poor Immune Response to Antiretroviral Therapy

(2011) Esther Merlini et al.   PLoS One

Increased epicardial adipose tissue volume in HIV-infected men and relationships to body composition and metabolic parameters

(2010) Janet Lo et al.   AIDS

Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy

(2010) Carl Grunfeld et al.   AIDS

European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142*

(2010) Todd Hulgan et al.   AIDS

Mitochondrial damage in adipose tissue of untreated HIV-infected patients

(2010) Glòria Garrabou et al.   AIDS

HIV Type 1 Alters Mesenchymal Stem Cell Differentiation Potential and Cell Phenotype ex Vivo

(2010) Eoin J. Cotter et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Potential Additional Effect of Omentectomy on Metabolic Syndrome, Acute-Phase Reactants, and Inflammatory Mediators in Grade III Obese Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass: A randomized trial

(2010) M. F. Herrera et al.   DIABETES CARE

Effects of Tesamorelin, a Growth Hormone-Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension

(2010) Julian Falutz et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Serum Insulin-Like Growth Factor I (IGF-I), IGF-Binding Proteins 2 and 3, and the Risk for Development of Malignancies in Adults with Growth Hormone (GH) Deficiency Treated with GH: Data from KIMS (Pfizer International Metabolic Database)

(2010) Vera Popovic et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of Tesamorelin (TH9507), a Growth Hormone-Releasing Factor Analog, in Human Immunodeficiency Virus-Infected Patients with Excess Abdominal Fat: A Pooled Analysis of Two Multicenter, Double-Blind Placebo-Controlled Phase 3 Trials with Safety Extension Data

(2010) Julian Falutz et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The HIV-1/HAART associated metabolic syndrome – Novel adipokines, molecular associations and therapeutic implications

(2010) S. Tsiodras et al.   JOURNAL OF INFECTION

Comparison of the influence of four classes of HIV antiretrovirals on adipogenic differentiation: the minimal effect of raltegravir and atazanavir

(2010) Rumi Minami et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Glyceroneogenesis is inhibited through HIV protease inhibitor-induced inflammation in human subcutaneous but not visceral adipose tissue

(2010) Stéphanie Leroyer et al.   JOURNAL OF LIPID RESEARCH

Growth hormone, the insulin-like growth factor axis, insulin and cancer risk

(2010) Peter E. Clayton et al.   Nature Reviews Endocrinology

HIV-associated lipodystrophy: from fat injury to premature aging

(2010) Martine Caron-Debarle et al.   TRENDS IN MOLECULAR MEDICINE

Differential gene expression indicates that ‘buffalo hump’ is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy

(2009) Jordi P Guallar et al.   AIDS

Effect of atazanavir and ritonavir on the differentiation and adipokine secretion of human subcutaneous and omental preadipocytes

(2009) Simon P Jones et al.   AIDS

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

(2009) Richard H Haubrich et al.   AIDS

How Much Fat Loss Is Needed for Lipoatrophy to Become Clinically Evident?

(2009) Daniel Podzamczer et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Mitochondrial (Dys)function in Adipocyte (De)differentiation and Systemic Metabolic Alterations

(2009) Aurélia De Pauw et al.   AMERICAN JOURNAL OF PATHOLOGY

Relation of Body Composition to Body Mass Index in HIV-Infected Patients With Metabolic Abnormalities

(2009) Tisha Joy et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Mitochondrial DNA Haplogroups Influence Lipoatrophy After Highly Active Antiretroviral Therapy

(2009) Sher L Hendrickson et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

The Effects of Recombinant Human Leptin on Visceral Fat, Dyslipidemia, and Insulin Resistance in Patients with Human Immunodeficiency Virus-Associated Lipoatrophy and Hypoleptinemia

(2009) Kathleen Mulligan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

CD57+ T lymphocytes and functional immune deficiency

(2009) Daniele Focosi et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters

(2009) Markus Feuerer et al.   NATURE MEDICINE

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

(2009) Satoshi Nishimura et al.   NATURE MEDICINE

Human gut microbiota in obesity and after gastric bypass

(2009) H. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: A substudy of the Multicenter AIDS Cohort Study

(2009) Todd T Brown et al.   AIDS Research and Therapy

Nonalcoholic Fatty Liver Disease in HIV‐Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors

(2008) Giovanni Guaraldi et al.   CLINICAL INFECTIOUS DISEASES

Proven Intra and Interobserver Reliability in the Echographic Assessments of Body Fat Changes Related to HIV Associated Adipose Redistribution Syndrome (HARS)

(2008) Rosario Gulizia et al.   CURRENT HIV RESEARCH

Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study

(2008) S. De Wit et al.   DIABETES CARE

Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy

(2008) HM Crane et al.   HIV MEDICINE

Management of Morphologic Changes Associated With Antiretroviral Use in HIV-Infected Patients

(2008) David Alain Wohl et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Approach to the Human Immunodeficiency Virus-Infected Patient with Lipodystrophy

(2008) Todd T. Brown   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Update on Obesity

(2008) Daniel H. Bessesen   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

GH/GHRH axis in HIV lipodystrophy

(2008) Takara L. Stanley et al.   Pituitary

Comparability of Echographic and Tomographic Assessments of Body Fat Changes Related to the HIV Associated Adipose Redistribution Syndrome (HARS) in Antiretroviral Treated Patients

(2008) Rosario Gulizia et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Excisional lipectomy for HIV-associated cervicodorsal lipodystrophy

(2008) A WARREN et al.   Aesthetic Surgery Journal

Human Immunodeficiency Virus (HIV)-1 Viral Protein R Suppresses Transcriptional Activity of Peroxisome Proliferator-Activated Receptor γ and Inhibits Adipocyte Differentiation: Implications for HIV-Associated Lipodystrophy

(2007) Shashi Shrivastav et al.   MOLECULAR ENDOCRINOLOGY